Mylan Insulin Glargine Study

Clinical trial NCT03376789 · COMPLETED

Trial details

NCT number: NCT03376789
Sponsor: Mylan Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2017-11-29
Primary completion: 2018-09-25
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.